Data on almost 370,000 people in the UK Biobank associated lifetime exposure to lower lipoprotein(a) levels with lower cardiovascular risk, researchers reported at the European Atherosclerosis Society 2019 Congress. Lower low-density lipoprotein cholesterol, gender and genetic variants that mimic antiplatelet therapy did not modify the effect, the study found.
Study evaluates effect of lower lipoprotein(a) levels
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.